7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-06-30 2021-03-31 2020-03-31 2018-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-03-31 2012-09-30 2012-06-30 2012-03-31 
      
    		                         
      cash flows from operating activities
    		                         
      net income
    		874,000,000 392,000,000 908,000,000 448,000,000 658,000,000 699,000,000 343,000,000 669,000,000 676,000,000 465,000,000 598,000,000 475,000,000 -264,000,000 376,000,000 636,000,000 587,000,000 634,000,000 738,000,000 1,074,000,000 558,000,000 93,000,000 1,000,000 297,000,000 290,000,000 200,000,000 
      adjustments to reconcile net income to net cash flows from operating activities:
    		                         
      depreciation, amortization, and accretion
    		913,000,000 901,000,000 905,000,000 894,000,000 880,000,000                     
      gain on sales of assets
    		  1,000,000             -2,000,000 -7,000,000 -1,000,000        
      deferred income taxes and amortization of investment tax credits
    		128,000,000 44,000,000 121,000,000 26,000,000 46,000,000 116,000,000 -19,000,000 113,000,000 113,000,000 33,000,000 110,000,000 -21,000,000 -142,000,000 -245,000,000 -14,000,000 30,000,000 82,000,000 129,000,000 326,000,000 181,000,000 -48,000,000 -610,000,000 36,000,000 126,000,000 101,000,000 
      net fair value changes related to derivatives
    		0 2,000,000 1,000,000  1,000,000 17,000,000   0 0 -59,000,000 -312,000,000 -178,000,000 -132,000,000 259,000,000 144,000,000 -416,000,000 -91,000,000 -229,000,000 21,000,000 730,000,000 388,000,000 -54,000,000 -250,000,000 -73,000,000 
      other non-cash operating activities
    		354,000,000 390,000,000 344,000,000 207,000,000 39,000,000 -15,000,000 -84,000,000 -138,000,000 -11,000,000 44,000,000 232,000,000 -161,000,000 -170,000,000 273,000,000 240,000,000 277,000,000 235,000,000 344,000,000 131,000,000 295,000,000 272,000,000 231,000,000 276,000,000 429,000,000 530,000,000 
      changes in assets and liabilities:
    		                         
      accounts receivable
    		38,000,000 -58,000,000 -402,000,000 -134,000,000 -309,000,000 -305,000,000 281,000,000 106,000,000 -254,000,000 -84,000,000 -711,000,000 356,000,000 -372,000,000 800,000,000 133,000,000 -78,000,000 523,000,000 -270,000,000 150,000,000 654,000,000 -606,000,000 -70,000,000 -174,000,000 20,000,000 394,000,000 
      inventories
    		-21,000,000 -37,000,000 17,000,000 -37,000,000 12,000,000 -52,000,000 -58,000,000 102,000,000 -133,000,000 -113,000,000 125,000,000 -76,000,000 77,000,000 81,000,000 167,000,000 -94,000,000 -132,000,000 291,000,000 -166,000,000 -230,000,000 80,000,000 101,000,000 -33,000,000 -59,000,000 104,000,000 
      accounts payable and accrued expenses
    		203,000,000 359,000,000 -397,000,000 118,000,000 -238,000,000 280,000,000 -252,000,000 -482,000,000 279,000,000 253,000,000 291,000,000 89,000,000 -176,000,000 -976,000,000 -451,000,000           
      collateral (paid) received
    		     4,000,000 27,000,000 -214,000,000                  
      income taxes
    		22,000,000 -62,000,000 59,000,000 -60,000,000 21,000,000 -47,000,000 74,000,000 23,000,000 -20,000,000 -54,000,000 77,000,000 77,000,000 113,000,000 -56,000,000 86,000,000 53,000,000 73,000,000 174,000,000 88,000,000 -33,000,000 17,000,000 632,000,000 206,000,000 81,000,000 178,000,000 
      regulatory assets and liabilities
    		-96,000,000 -380,000,000 86,000,000 13,000,000 252,000,000 121,000,000 -192,000,000 -324,000,000 -313,000,000                 
      pension and non-pension postretirement benefit contributions
    		-11,000,000 -10,000,000 -292,000,000 -14,000,000 -111,000,000 -12,000,000 -41,000,000 -44,000,000 -11,000,000 -11,000,000 -574,000,000 -22,000,000 -537,000,000 -531,000,000 -331,000,000 -129,000,000 -32,000,000 -269,000,000 -17,000,000 -27,000,000 -472,000,000 -267,000,000 -41,000,000 -35,000,000 -55,000,000 
      other assets and liabilities
    		-65,000,000 1,000,000 -195,000,000 3,000,000 -264,000,000 -164,000,000 327,000,000 -187,000,000 -63,000,000 -78,000,000 -645,000,000 -862,000,000 -1,840,000,000 -488,000,000 -495,000,000 -694,000,000 99,000,000 115,000,000 -256,000,000 -2,000,000 -278,000,000 233,000,000 -74,000,000 -235,000,000 -122,000,000 
      net cash flows from operating activities
    		2,299,000,000 1,511,000,000 1,200,000,000 1,462,000,000 992,000,000 1,531,000,000 1,277,000,000 484,000,000 901,000,000 1,458,000,000 1,782,000,000 2,399,000,000 -1,261,000,000 1,080,000,000 1,502,000,000 1,705,000,000 2,479,000,000 1,490,000,000 1,892,000,000 1,586,000,000 165,000,000 859,000,000 1,828,000,000 1,735,000,000 994,000,000 
      cash flows from investing activities
    		                         
      capital expenditures
    		-2,136,000,000 -2,013,000,000 -1,946,000,000 -1,699,000,000 -1,767,000,000 -1,855,000,000 -1,804,000,000 -1,881,000,000 -1,672,000,000 -1,585,000,000 -1,922,000,000 -1,900,000,000 -2,140,000,000 -2,016,000,000 -1,880,000,000 -1,983,000,000 -1,676,000,000 -1,784,000,000 -1,613,000,000 -1,284,000,000 -1,217,000,000 -1,447,000,000 -1,329,000,000 -1,320,000,000 -1,496,000,000 
      free cash flows
    		163,000,000 -502,000,000 -746,000,000 -237,000,000 -775,000,000 -324,000,000 -527,000,000 -1,397,000,000 -771,000,000 -127,000,000 -140,000,000 499,000,000 -3,401,000,000 -936,000,000 -378,000,000 -278,000,000 803,000,000 -294,000,000 279,000,000 302,000,000 -1,052,000,000 -588,000,000 499,000,000 415,000,000 -502,000,000 
      proceeds from sales of assets
    		0                         
      other investing activities
    		-2,000,000 -9,000,000 4,000,000 1,000,000 -2,000,000 15,000,000 0 10,000,000 32,000,000 58,000,000 -54,000,000 5,000,000 12,000,000 -8,000,000 3,000,000 -30,000,000 -75,000,000 -2,000,000 -29,000,000 -3,000,000 -54,000,000 40,000,000 53,000,000 47,000,000 -59,000,000 
      net cash flows used in investing activities
    		-2,138,000,000 -2,020,000,000 -1,942,000,000 -1,700,000,000 -1,767,000,000 -1,840,000,000 -1,804,000,000 -1,871,000,000 -1,640,000,000     -2,075,000,000 -1,857,000,000 -2,143,000,000 -1,795,000,000 -1,751,000,000 -1,189,000,000 -1,176,000,000 -1,011,000,000 -1,471,000,000 -1,341,000,000 -1,344,000,000 -640,000,000 
      cash flows from financing activities
    		                         
      changes in short-term borrowings
    		-29,000,000 25,000,000 -775,000,000 -353,000,000 -317,000,000 484,000,000 -470,000,000 -1,130,000,000 262,000,000 103,000,000 -700,000,000 -1,263,000,000 597,000,000 109,000,000 726,000,000 136,000,000 235,000,000 -141,000,000 -57,000,000 -345,000,000 638,000,000     
      proceeds from short-term borrowings with maturities greater than 90 days
    		   0 150,000,000 0   0 0 1,150,000,000 0 500,000,000 500,000,000 1,000,000           
      repayments on short-term borrowings with maturities greater than 90 days
    		   -399,000,000 -150,000,000 0 0 -150,000,000 -575,000,000 0 -350,000,000    -1,000,000           
      issuance of long-term debt
    		1,125,000,000 1,375,000,000 2,425,000,000 1,600,000,000 2,625,000,000 100,000,000 1,275,000,000 3,925,000,000 650,000,000 850,000,000 4,301,000,000 750,000,000 1,705,000,000 2,652,000,000 1,130,000,000 2,000,000 4,701,000,000 1,206,000,000 1,112,000,000 1,150,000,000 950,000,000 149,000,000 708,000,000   
      retirement of long-term debt
    		0   -2,000,000 -901,000,000 0 -352,000,000 -857,000,000 -360,000,000 -1,701,000,000 -6,000,000 -551,000,000 -79,000,000 -1,032,000,000 -1,241,000,000 -37,000,000 -1,128,000,000 -580,000,000 -23,000,000 -41,000,000 -1,150,000,000 -1,000,000 -82,000,000 -198,000,000 -451,000,000 
      issuance of common stock
    		0 0 173,000,000                       
      dividends paid on common stock
    		-404,000,000 -405,000,000 -403,000,000 -380,000,000 -381,000,000 -357,000,000 -359,000,000 -358,000,000 -336,000,000 -331,000,000 -332,000,000 -373,000,000 -374,000,000 -373,000,000 -333,000,000 -282,000,000 -268,000,000 -269,000,000 -266,000,000 -267,000,000 -266,000,000 -450,000,000 -453,000,000 -423,000,000 -350,000,000 
      proceeds from employee stock plans
    		13,000,000   11,000,000 11,000,000 11,000,000 9,000,000 10,000,000 9,000,000 8,000,000 9,000,000 16,000,000 31,000,000 30,000,000 12,000,000 8,000,000 8,000,000 8,000,000 7,000,000 11,000,000 7,000,000 12,000,000 19,000,000 30,000,000 12,000,000 
      other financing activities
    		-19,000,000 -21,000,000 -35,000,000 -12,000,000 -55,000,000 -17,000,000 -24,000,000 -60,000,000 -37,000,000 -22,000,000 -62,000,000 -18,000,000 -46,000,000 -21,000,000 -30,000,000 -6,000,000 -43,000,000 -16,000,000 -75,000,000 -55,000,000 -28,000,000 -45,000,000 -10,000,000 -9,000,000 -1,000,000 
      net cash flows from financing activities
    		686,000,000 178,000,000 1,385,000,000 465,000,000 982,000,000 221,000,000 479,000,000 1,380,000,000 176,000,000 -1,093,000,000 1,416,000,000 -1,439,000,000 2,334,000,000 1,865,000,000 264,000,000 1,689,000,000 3,505,000,000 208,000,000 698,000,000 38,000,000 151,000,000  -136,000,000 237,000,000 -649,000,000 
      increase in cash, restricted cash, and cash equivalents
    		847,000,000 -331,000,000 643,000,000 227,000,000 207,000,000  -48,000,000 -7,000,000 -563,000,000 -1,162,000,000 1,379,000,000 -325,000,000 1,168,000,000             
      cash, restricted cash, and cash equivalents at beginning of period
    		0 0 939,000,000 0 1,101,000,000 0 0 1,090,000,000 0 0 1,619,000,000 0 1,166,000,000             
      cash, restricted cash, and cash equivalents at end of period
    		847,000,000 -331,000,000 1,582,000,000 227,000,000 1,308,000,000 -88,000,000 -48,000,000 1,083,000,000 -563,000,000 -1,162,000,000 2,998,000,000 -325,000,000 2,334,000,000             
      supplemental cash flow information
    		                         
      increase in capital expenditures not paid
    		                         
      increase in pp&e related to aro update
    		        666,000,000 0 -335,000,000               
      collateral received
    		 -30,000,000 44,000,000      -233,000,000 547,000,000 1,142,000,000               
      decrease in capital expenditures not paid
    		 116,000,000 -216,000,000 43,000,000 -117,000,000 -5,000,000 37,000,000 -201,000,000 129,000,000 46,000,000 -322,000,000 11,000,000 -324,000,000 -180,000,000            
      collateral received (paid)
    		   6,000,000 7,000,000                     
      gain on sales of assets and businesses
    		    -2,000,000    0 2,000,000 -10,000,000 -12,000,000 -71,000,000  -56,000,000           
      proceeds from sales of assets and businesses
    		    2,000,000    0 0 16,000,000 44,000,000 680,000,000  79,000,000           
      depreciation, amortization, and accretion, including nuclear fuel and energy contract amortization
    		     889,000,000 867,000,000 860,000,000 825,000,000 830,000,000 1,024,000,000 2,076,000,000 2,104,000,000             
      asset impairments
    		           499,000,000 1,000,000 8,000,000            
      net realized and unrealized losses on ndt funds
    		                         
      net unrealized losses on equity investments
    		          16,000,000               
      option premiums paid
    		              -27,000,000       -3,000,000    
      proceeds from ndt fund sales
    		        0 0 488,000,000 1,530,000,000 2,908,000,000 1,183,000,000            
      investment in ndt funds
    		        0 0 -516,000,000 -1,599,000,000 -2,939,000,000 -1,234,000,000            
      collection of dpp
    		        0 0 169,000,000 635,000,000 1,574,000,000             
      transfer of cash, restricted cash, and cash equivalents to constellation
    		        0 0 -2,594,000,000               
      decrease in cash, restricted cash, and cash equivalents
    		                         
      increase in dpp
    		        0 0 348,000,000 619,000,000 1,339,000,000             
      decrease in pp&e related to aro update
    		                         
      net realized and unrealized losses (gains) on ndt funds
    		        0 0 205,000,000   651,000,000            
      acquisition of ceng noncontrolling interest
    		                         
      net unrealized losses (gains) on equity investments
    		                         
      option premiums (paid) received
    		         0 -39,000,000   -38,000,000         -14,000,000 -8,000,000 -100,000,000 
      net cash flows from investing activities
    		          -1,819,000,000  95,000,000             
      net realized and unrealized (gains) losses on ndt funds
    		           -258,000,000 -118,000,000             
      net unrealized gains on equity investments
    		                         
      option premiums received (paid)
    		           -14,000,000 16,000,000      0 6,000,000 15,000,000     
      unrealized loss on equity investments
    		            23,000,000             
      collateral received (posted)
    		            273,000,000             
      depreciation, amortization and accretion, including nuclear fuel and energy contract amortization
    		             1,378,000,000 1,501,000,000           
      collateral posted
    		             -21,000,000 -214,000,000           
      increase in cash, cash equivalents and restricted cash
    		             870,000,000            
      cash, cash equivalents and restricted cash at beginning of period
    		             1,122,000,000 1,190,000,000           
      cash, cash equivalents and restricted cash at end of period
    		             1,992,000,000 1,099,000,000           
      increase in ppe related to aro update
    		                         
      impairment of long-lived assets and losses on regulatory assets
    		                         
      bargain purchase gain
    		                         
      net realized and unrealized gains on nuclear decommissioning trust fund investments
    		              68,000,000  45,000,000 -47,000,000 27,000,000 -142,000,000 -26,000,000 -66,000,000  33,000,000 -103,000,000 
      proceeds from nuclear decommissioning trust fund sales
    		              1,189,000,000 1,237,000,000 1,633,000,000 1,681,000,000 1,245,000,000 2,394,000,000 1,825,000,000 677,000,000 891,000,000 1,691,000,000 3,680,000,000 
      investment in nuclear decommissioning trust funds
    		              -1,248,000,000 -1,300,000,000 -1,690,000,000 -1,747,000,000 -1,312,000,000 -2,360,000,000 -1,878,000,000 -729,000,000 -939,000,000 -1,757,000,000 -3,726,000,000 
      acquisition of businesses
    		               0 -13,000,000 -15,000,000        
      decrease in cash, cash equivalents and restricted cash
    		              -91,000,000           
      depreciation, amortization, depletion and accretion, including nuclear fuel and energy contract amortization
    		               973,000,000 1,009,000,000 948,000,000 931,000,000 1,017,000,000 908,000,000 1,017,000,000    
      impairment of long-lived assets
    		               1,000,000          
      gain on consolidation and acquisition of businesses
    		                         
      net realized and unrealized (gains) losses on nuclear decommissioning trust fund investments
    		                         
      accounts payable, accrued expenses and other current liabilities
    		               521,000,000 -61,000,000 -607,000,000 36,000,000 -515,000,000 157,000,000 -542,000,000 226,000,000 113,000,000 -1,176,000,000 
      option premiums received
    		               5,000,000 17,000,000 5,000,000        
      counterparty collateral received (posted)
    		               -112,000,000 386,000,000 31,000,000    -186,000,000 -43,000,000 111,000,000 340,000,000 
      proceeds from sale of long-lived assets
    		               0 3,000,000 142,000,000 628,000,000 14,000,000 18,000,000     
      proceeds from termination of direct financing lease investment
    		                  0 0 335,000,000     
      proceeds from sales of investments
    		                      14,000,000 2,000,000 10,000,000 
      cash and restricted cash acquired from consolidations and acquisitions
    		                         
      change in restricted cash
    		               -67,000,000 23,000,000 -26,000,000 -111,000,000 0 -40,000,000 -12,000,000 -23,000,000 -7,000,000 -8,000,000 
      distributions to noncontrolling interest of consolidated vie
    		                         
      increase in cash and cash equivalents
    		               1,251,000,000       351,000,000   
      cash and cash equivalents at beginning of period
    		               0 0 1,878,000,000 0 0 1,609,000,000 1,486,000,000 0 0 1,016,000,000 
      cash and cash equivalents at end of period
    		               1,251,000,000 4,189,000,000 1,825,000,000 1,401,000,000 448,000,000 914,000,000 772,000,000 351,000,000 628,000,000 721,000,000 
      decrease in cash and cash equivalents
    		                 -53,000,000  448,000,000 -695,000,000 -714,000,000   -295,000,000 
      gain on consolidation of ceng
    		                  0       
      gain on sale of assets
    		                         
      counterparty collateral posted
    		                  -9,000,000 71,000,000 -677,000,000     
      proceeds from sale of investments
    		                         
      purchases of investments
    		                      -8,000,000 0 -5,000,000 
      cash consolidated from ceng
    		                  0       
      payment of accounts receivable agreement
    		                         
      redemption of preferred securities
    		                         
      acquisition of business
    		                         
      distributions to non-controlling interest of consolidated vie
    		                         
      impairment of assets held for sale
    		                         
      counterparty collateral (posted) received
    		                         
      cash and restricted cash acquired from constellation
    		                         
      changes in short-term debt
    		                     233,000,000 -318,000,000 38,000,000 141,000,000 
      dividends paid to former constellation shareholders
    		                      0   
      net cash flows used in financing activities
    		                     -102,000,000    
      depreciation, amortization, accretion and depletion including nuclear fuel and energy contract amortization
    		                      1,014,000,000 1,119,000,000 776,000,000 
      acquisitions
    		                         
      cash acquired from constellation
    		                      0 0 964,000,000 
      depreciation, amortization and accretion, including nuclear fuel amortization
    		                         
      retirement of long-term debt of variable interest entity
    		                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.